Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Reaman

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Clinical Trials (London, England)|August 3, 2017
Commentary on Heath et alVirginia Kwitkowski, Selena Daniels, Gregory Reaman, et al.
Clinical Pharmacology and Therapeutics|July 9, 2023
Assessing Information Gaps Associated with Initial Pediatric Study Plans for New Oncology Drug and Biological ProductsDaphne Guinn, Marilyn Gafford, Gilbert J Burckart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plansAlberto S Pappo, Mark Krailo, Zhengjia Chen, et al.
Journal of the National Cancer Institute|May 12, 2023
Clinical development of new drugs for adults and children with cancer, 2010-2020Andrea Arfè, Claire Narang, Steven G DuBois, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 31, 2007
The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology GroupLisa A Teot, Richard Sposto, Anita Khayat, et al.
Mabs|November 5, 2022
A mouse pancreatic organoid model to compare PD-L1 blocking antibodiesGuangyuan Li, Susmita Ghosh, JuMe Park, et al.
Pediatric Blood & Cancer|August 3, 2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group reportJanet L Franklin, Nita L Seibel, Mark Krailo, et al.
CA: a Cancer Journal for Clinicians|May 5, 2016
Advancing a comprehensive cancer care agenda for children and their families: Institute of Medicine Workshop highlights and next stepsRebecca Kirch, Gregory Reaman, Chris Feudtner, et al.
Journal of Clinical Pharmacology|September 19, 2017
Bridging Adult Experience to Pediatrics in Oncology Drug DevelopmentRuby Leong, Hong Zhao, Gregory Reaman, et al.
Pediatric Blood & Cancer|July 1, 2014
International patterns of childhood chronic myeloid leukemia: comparisons between the United States and resource-restricted nationsKarim Thomas Sadak, Kara Fultz, Adam Mendizabal, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Clinical Trials (London, England)|August 3, 2017
Commentary on Heath et alVirginia Kwitkowski, Selena Daniels, Gregory Reaman, et al.
Clinical Pharmacology and Therapeutics|July 9, 2023
Assessing Information Gaps Associated with Initial Pediatric Study Plans for New Oncology Drug and Biological ProductsDaphne Guinn, Marilyn Gafford, Gilbert J Burckart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plansAlberto S Pappo, Mark Krailo, Zhengjia Chen, et al.
Journal of the National Cancer Institute|May 12, 2023
Clinical development of new drugs for adults and children with cancer, 2010-2020Andrea Arfè, Claire Narang, Steven G DuBois, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 31, 2007
The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology GroupLisa A Teot, Richard Sposto, Anita Khayat, et al.
Mabs|November 5, 2022
A mouse pancreatic organoid model to compare PD-L1 blocking antibodiesGuangyuan Li, Susmita Ghosh, JuMe Park, et al.
Pediatric Blood & Cancer|August 3, 2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group reportJanet L Franklin, Nita L Seibel, Mark Krailo, et al.
CA: a Cancer Journal for Clinicians|May 5, 2016
Advancing a comprehensive cancer care agenda for children and their families: Institute of Medicine Workshop highlights and next stepsRebecca Kirch, Gregory Reaman, Chris Feudtner, et al.
Journal of Clinical Pharmacology|September 19, 2017
Bridging Adult Experience to Pediatrics in Oncology Drug DevelopmentRuby Leong, Hong Zhao, Gregory Reaman, et al.
Pediatric Blood & Cancer|July 1, 2014
International patterns of childhood chronic myeloid leukemia: comparisons between the United States and resource-restricted nationsKarim Thomas Sadak, Kara Fultz, Adam Mendizabal, et al.
Pageof 9